Human immune interferon
US4727138A · kind A · utility
95Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1985 |
| Grant date | Feb 23, 1988 |
| Priority date | — |
| Expiry date | Sep 11, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a complete description of the preparation of novel, substantially pure polypeptide via recombinant DNA techniques utilizing any of an assortment of expression vectors and host cultures. The polypeptide, human immune (gamma) interferon (IFN-.gamma.), is isolated and characterized in terms of DNA and amino acid sequences, physical attributes and biological activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.